Edesa Biotech Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	10	10.79	1.04	5.36	7.09	7.84
Cash & Short-Term Investments	10	10.79	1.04	5.36	7.09	7.84
Cash Growth	-28.01%	940.39%	-80.65%	-24.39%	-9.55%	8.67%
Accounts Receivable	0.22	0.64	0.27	0.63	1.26	3.3
Other Current Assets	0.2	0.08	0.37	0.45	0.75	0.95
Total Current Assets	10.42	11.51	1.68	6.44	9.09	12.09
Net Property, Plant & Equipment	-	-	0.02	0.1	0.03	0.11
Other Intangible Assets	1.93	1.98	2.08	2.18	2.28	2.38
Other Long-Term Assets	0.04	0.04	0.04	0.17	0.17	-
Total Assets	12.38	13.53	3.81	8.89	11.58	14.58
Accounts Payable	2.19	1.08	1.81	1.75	2.12	1.38
Current Portion of Leases	-	-	0.02	0.07	0.02	0.08
Total Current Liabilities	2.19	1.08	1.83	1.82	2.14	1.46
Long-Term Leases	-	-	-	0.02	-	0.02
Other Long-Term Liabilities	-	-	-	-	0.04	0.05
Total Long-Term Liabilities	-	-	-	0.02	0.04	0.07
Total Liabilities	2.19	1.08	1.83	1.84	2.18	1.53
Preferred Stock	8.37	9.26	-	-	-	-
Common Stock	58.93	54.52	47.24	46.64	42.47	34.89
Additional Paid-in Capital	15.53	14.75	13.58	13.04	11.18	4.87
Accumulated Other Comprehensive Income	-0.19	-0.17	-0.24	-0.21	-0.21	-0.21
Retained Earnings	-72.45	-65.91	-58.59	-52.42	-44.04	-26.5
Total Common Shareholders' Equity	10.2	12.45	1.98	7.05	9.39	13.06
Shareholders' Equity	10.2	12.45	1.98	7.05	9.39	13.06
Total Liabilities & Equity	12.38	13.53	3.81	8.89	11.58	14.58
Total Debt	-	0	0.02	0.09	0.02	0.1
Net Cash (Debt)	10	10.79	1.02	5.27	7.07	7.74
Net Cash Growth	-7.31%	960.70%	-80.68%	-25.52%	-8.63%	9.79%
Net Cash Per Share	1.31	1.90	0.32	1.71	3.07	4.45
Book Value	10.2	12.45	1.98	7.05	9.39	13.06
Book Value Per Share	1.33	2.19	0.62	2.29	4.08	7.50
Tangible Book Value	8.27	10.47	-0.1	4.87	7.11	10.68
Tangible Book Value Per Share	1.08	1.85	-0.03	1.58	3.09	6.14

SEC Filings: 10-K · 10-Q